Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

154 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
Vaccination invitations sent by warm and competent medical professionals disclosing risks and benefits increase trust and booking intention and reduce inequalities between ethnic groups.
Juanchich M, Oakley CM, Sayer H, Holford DL, Bruine de Bruin W, Booker C, Chadborn T, Vallee-Tourangeau G, Wood RM, Sirota M. Juanchich M, et al. Among authors: sayer h. Health Psychol. 2024 Oct;43(10):718-729. doi: 10.1037/hea0001385. Epub 2024 Jun 17. Health Psychol. 2024. PMID: 38884977
Treatment of newly diagnosed moderate or severe chronic graft-versus-host disease with prednisone and everolimus (PredEver first): a prospective multicenter phase IIA study.
Ayuk F, Wagner-Drouet EM, Wolff D, von Huenerbein N, von Pein UM, Klyuchnikov E, von Harsdorf S, Koenecke C, Sayer H, Kröger N. Ayuk F, et al. Among authors: sayer h. Bone Marrow Transplant. 2024 Aug;59(8):1092-1096. doi: 10.1038/s41409-024-02289-0. Epub 2024 May 2. Bone Marrow Transplant. 2024. PMID: 38698080 Free PMC article. Clinical Trial.
Different treatment strategies versus a common standard arm (CSA) in patients with newly diagnosed AML over the age of 60 years: a randomized German inter-group study.
Niederwieser D, Lang T, Krahl R, Heinicke T, Maschmeyer G, Al-Ali HK, Schwind S, Jentzsch M, Cross M, Kahl C, Wolf HH, Sayer H, Schulze A, Dreger P, Hegenbart U, Krämer A, Junghanss C, Mügge LO, Hähling D, Hirt C, Späth C, Peter N, Opitz B, Florschütz A, Reifenrath K, Zojer N, Scholl S, Pönisch W, Heyn S, Vucinic V, Hochhaus A, Aul C, Giagounidis A, Balleisen L, Oldenkott B, Staib P, Kiehl M, Schütte W, Naumann R, Eimermacher H, Dörken B, Sauerland C, Lengfelder E, Hiddemann W, Wörmann B, Müller-Tidow C, Serve H, Schliemann C, Hehlmann R, Berdel WE, Pfirrmann M, Krug U, Hoffmann VS. Niederwieser D, et al. Among authors: sayer h. Ann Hematol. 2023 Mar;102(3):547-561. doi: 10.1007/s00277-023-05087-8. Epub 2023 Jan 25. Ann Hematol. 2023. PMID: 36695874 Free PMC article.
Outcome of patients with relapsed or refractory acute myeloid leukemia treated with Mito-FLAG salvage chemotherapy.
Mühleck R, Scholl S, Hilgendorf I, Schrenk K, Hammersen J, Frietsch JJ, Fleischmann M, Sayer HG, Glaser A, Hochhaus A, Schnetzke U. Mühleck R, et al. Among authors: sayer hg. J Cancer Res Clin Oncol. 2022 Sep;148(9):2539-2548. doi: 10.1007/s00432-021-03821-1. Epub 2021 Oct 5. J Cancer Res Clin Oncol. 2022. PMID: 34609595 Free PMC article.
Correction to: Allogeneic hematopoietic stem cell transplantation improves long‑term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Heinicke T, Krahl R, Kahl C, Cross M, Scholl S, Wolf HH, Hähling D, Hegenbart U, Peter N, Schulze A, Florschütz A, Schmidt V, Reifenrath K, Zojer N, Junghanss C, Sayer HG, Maschmeyer G, Späth C, Hochhaus A, Fischer T, Al-Ali HK, Niederwieser D. Heinicke T, et al. Among authors: sayer hg. Ann Hematol. 2021 Nov;100(11):2877-2878. doi: 10.1007/s00277-021-04638-1. Ann Hematol. 2021. PMID: 34529106 Free PMC article. No abstract available.
Impact of induction chemotherapy with intermediate-dosed cytarabine and subsequent allogeneic stem cell transplantation on the outcome of high-risk acute myeloid leukemia.
Fleischmann M, Schnetzke U, Frietsch JJ, Sayer HG, Schrenk K, Hammersen J, Glaser A, Hilgendorf I, Hochhaus A, Scholl S. Fleischmann M, et al. Among authors: sayer hg. J Cancer Res Clin Oncol. 2022 Jun;148(6):1481-1492. doi: 10.1007/s00432-021-03733-0. Epub 2021 Jul 23. J Cancer Res Clin Oncol. 2022. PMID: 34297206 Free PMC article.
Full or intensity-reduced high-dose melphalan and single or double autologous stem cell transplant with or without bortezomib consolidation in patients with newly diagnosed multiple myeloma.
Straka C, Salwender H, Knop S, Vogel M, Müller J, Metzner B, Langer C, Sayer H, Jung W, Dürk HA, Bassermann F, Gramatzki M, Rösler W, Wolf HH, Brugger W, Engelhardt M, Fischer T, Liebisch P, Einsele H. Straka C, et al. Among authors: sayer h. Eur J Haematol. 2021 Nov;107(5):529-542. doi: 10.1111/ejh.13690. Epub 2021 Aug 28. Eur J Haematol. 2021. PMID: 34270825
Allogeneic hematopoietic stem cell transplantation improves long-term outcome for relapsed AML patients across all ages: results from two East German Study Group Hematology and Oncology (OSHO) trials.
Heinicke T, Krahl R, Kahl C, Cross M, Scholl S, Wolf HH, Hähling D, Hegenbart U, Peter N, Schulze A, Florschütz A, Schmidt V, Reifenrath K, Zojer N, Junghanss C, Sayer HG, Maschmeyer G, Späth C, Hochhaus A, Fischer T, Al-Ali HK, Niederwieser D. Heinicke T, et al. Among authors: sayer hg. Ann Hematol. 2021 Sep;100(9):2387-2398. doi: 10.1007/s00277-021-04565-1. Epub 2021 Jul 7. Ann Hematol. 2021. PMID: 34232360 Free PMC article. Clinical Trial.
Allogeneic stem cell transplantation for mantle cell lymphoma-update of the prospective trials of the East German Study Group Hematology/Oncology (OSHO#60 and #74).
Krüger WH, Hirt C, Basara N, Sayer HG, Behre G, Fischer T, Grobe N, Maschmeyer G, Neumann T, Schneidewind L, Niederwieser D, Dölken G, Schmidt CA. Krüger WH, et al. Among authors: sayer hg. Ann Hematol. 2021 Jun;100(6):1569-1577. doi: 10.1007/s00277-021-04506-y. Epub 2021 Apr 8. Ann Hematol. 2021. PMID: 33829299 Free PMC article. Clinical Trial.
154 results